This is the first trial reporting successful transplant in dyskeratosis congenita (DC) patients without the use of any radiation or
conventional cytotoxic chemotherapy beforehand.
No targeted therapy has been approved for noninflammatory and inflammatory triple - negative breast cancer tumors, and the standard of therapy for these tumors is a combination of
conventional cytotoxic chemotherapeutic agents.
Not exact matches
Conventional transplant conditioning employs radiation and / or high - dose
cytotoxic drugs (also known as alkylators) to destroy the bone marrow and blood and immune cells; it also causes widespread cellular damage throughout the body.
Heretofore, treatment of patients with primary or light chain - associated (AL) amyloidosis has been directed toward reducing the synthesis of the amyloidogenic precursor protein through
conventional or high - dose
cytotoxic antiplasma cell chemotherapy.